Back to search
FDAFDA · Food and drugs·Recall number D-1284-2020

Estriol USP Micronized 5 G, Rx only, Triova 115 W 3rd Street Suite 720 Tulsa, OK 74103, NDC 71092-9977-02

Published June 10, 2020 · Recall initiated: May 15, 2020

Summary

FDA records drug Class II recall D-1284-2020, published June 10, 2020 and initiated May 15, 2020. Recalling firm: TRIOVA PHARMACEUTICALS LLC; Status: Terminated; Reported quantity: 210 grams; Lot: Lot #:17010401181119190927, EXP 12/2020, 1701040118111919092725200122, EXP.12/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed impurities/ degradation specifications: Out of specification for organic impurities.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
TRIOVA PHARMACEUTICALS LLC
Distributor
U.S.A. Nationwide
Lot
Lot #:17010401181119190927, EXP 12/2020, 1701040118111919092725200122, EXP.12/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Estriol USP Micronized 5 G, Rx only, Triova 115 W 3rd Street Suite 720 Tulsa, OK 74103, NDC 71092-9977-02 recalled?

Yes. FDA published recall D-1284-2020 on June 10, 2020. Reported hazard: Failed impurities/ degradation specifications: Out of specification for organic impurities.

What should I do if I have this product?

Voluntary: Firm initiated · Letter